http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104327159-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06 |
| filingDate | 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104327159-B |
| titleOfInvention | Mycobacterium tuberculosis specific C D8+T cell epitope peptide P45 and its application |
| abstract | The invention discloses a kind of mycobacterium tuberculosis specific C D8 + T cell epitope peptide and its application.The amino acid sequence of the epitope peptide is RLIPFAAPPK, and the epitope peptide is high with HLA A*1101 molecules affinity, can activate CD8+T cells, induce it to breed and secrete IFN γ.The determination of epitope peptide of the present invention, theoretical foundation and new solution are provided for the research and development of tuberculosis vaccine, diagnostic reagent and medicine, preventing and treating lungy is significant. |
| priorityDate | 2014-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 284.